These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32041849)

  • 1. The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: implications in aging and cancer.
    Ghosh P; Swanson L; Sayed IM; Mittal Y; Lim BB; Ibeawuchi SR; Foretz M; Viollet B; Sahoo D; Das S
    Life Sci Alliance; 2020 Mar; 3(3):. PubMed ID: 32041849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults.
    Ghosh P
    Aging (Albany NY); 2017 Feb; 9(2):303-314. PubMed ID: 28209925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis.
    Olivier S; Pochard C; Diounou H; Castillo V; Divoux J; Alcantara J; Leclerc J; Guilmeau S; Huet C; Charifi W; Varin TV; Daniel N; Foretz M; Neunlist M; Salomon BL; Ghosh P; Marette A; Rolli-Derkinderen M; Viollet B
    Mol Metab; 2021 May; 47():101183. PubMed ID: 33548500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.
    Kinashi Y; Hase K
    Front Immunol; 2021; 12():673708. PubMed ID: 33968085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    Ozaka S; Sonoda A; Ariki S; Minata M; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Dewayani A; Chalalai T; Ozaki T; Soga Y; Fukuda C; Mizukami K; Ishizawa S; Nishiyama M; Fujitsuka N; Mogami S; Kubota K; Murakami K; Kobayashi T
    PLoS One; 2022; 17(6):e0269698. PubMed ID: 35704618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut barrier and chronic diseases.
    Santilli A; Stefanopoulos S; Cresci GAM
    Curr Opin Clin Nutr Metab Care; 2022 May; 25(3):178-185. PubMed ID: 35125386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life.
    Takiishi T; Fenero CIM; Câmara NOS
    Tissue Barriers; 2017 Oct; 5(4):e1373208. PubMed ID: 28956703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of Intestinal Barrier Function Induced by Early Weaning
    Tang W; Liu J; Ma Y; Wei Y; Liu J; Wang H
    Front Immunol; 2021; 12():804870. PubMed ID: 34975919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin αVβ5 receptor.
    Bi J; Zhang J; Ren Y; Du Z; Li T; Wang T; Zhang L; Wang M; Wu Z; Lv Y; Wu R
    J Cell Mol Med; 2020 Jan; 24(1):996-1009. PubMed ID: 31701659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice.
    Ma L; Ni Y; Wang Z; Tu W; Ni L; Zhuge F; Zheng A; Hu L; Zhao Y; Zheng L; Fu Z
    Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 33151120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity.
    Allaire JM; Crowley SM; Law HT; Chang SY; Ko HJ; Vallance BA
    Trends Immunol; 2018 Sep; 39(9):677-696. PubMed ID: 29716793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host engulfment pathway controls inflammation in inflammatory bowel disease.
    Sayed IM; Suarez K; Lim E; Singh S; Pereira M; Ibeawuchi SR; Katkar G; Dunkel Y; Mittal Y; Chattopadhyay R; Guma M; Boland BS; Dulai PS; Sandborn WJ; Ghosh P; Das S
    FEBS J; 2020 Sep; 287(18):3967-3988. PubMed ID: 32003126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases.
    Dey P
    Pharmacol Res; 2020 Nov; 161():105135. PubMed ID: 32814166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.
    Miranda-Ribera A; Ennamorati M; Serena G; Cetinbas M; Lan J; Sadreyev RI; Jain N; Fasano A; Fiorentino M
    Front Immunol; 2019; 10():2233. PubMed ID: 31608059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Regulatory Effects of Licochalcone A on the Intestinal Epithelium and Gut Microbiota in Murine Colitis.
    Zhang J; Cao L; Sun Y; Qing DG; Xu XQ; Wang JC; Si JY; Li N
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut barrier disruption and chronic disease.
    Martel J; Chang SH; Ko YF; Hwang TL; Young JD; Ojcius DM
    Trends Endocrinol Metab; 2022 Apr; 33(4):247-265. PubMed ID: 35151560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis.
    Brandl C; Bucci L; Schett G; Zaiss MM
    Eur J Immunol; 2021 Apr; 51(4):798-810. PubMed ID: 33594693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.